¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
3/28ÀÏ ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2020-03-27
Á¶È¸¼ö
302


¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù. 

À̹øÁÖ Åä¿äÀÏ ¼¼¹Ì³ª¿¡¼­ ¹ßÇ¥µå¸± ³í¹®Àº 
2016³â nature immunology¿¡¼­ ¹ßÇ¥ µÇ¾ú´ø, 
"The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation."

ÀÔ´Ï´Ù. cross-presentationÀ» ¿¬±¸ÇÏ´Â ÁÖ¿ä ¿¬±¸ÆÀµéÀÇ ¿¬±¸¿¡¼­ TLR-4 ligand¿¡ ÀÇÇؼ­ TFEB, rab34µî cross-presentationÀ» Á¶ÀýÇÏ´Â ÀÎÀÚµéÀÌ ¹àÇôÁø ÈÄ, Siglec-G¶ó´Â lectin receptor°¡ cross-presentation À» ÁÖ·Î ÇÑ´Ù°í ¾Ë·ÁÁø CD8+ DC¿Í ±×·¸Áö ¾ÊÀº CD8- DC¿¡¼­ ¹ßÇö¾ç»óÀÌ Å©°Ô Â÷À̸¦ º¸ÀÌ°í, OVA¸¦ ¹ßÇôÇÏ´Â bacteria °¨¿°¸ðµ¨, tumor modelµéÀ» ¹ÙÅÁÀ¸·Î Siglec-G°¡  cross-presentationÀ» inhibitoryÇÏ°Ô Á¶ÀýÇÑ´Ù´Â °ÍÀ» ¹àÈù ³í¹®ÀÔ´Ï´Ù. 

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù. 
³í¹® ¸µÅ© : https://www.nature.com/articles/ni.3535
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
4/4 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ Æò¿µÁø
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº 2018³âµµ JEM¿¡ ÃâÆÇ µÈ "The E3 ligase VHL controls alveolar macrophage function via metabolic–epigenetic regulation" ÀÔ´Ï´Ù. Macrophage³»ºÎÀÇmetabolic pathway º¯È­´Âmacrophage function¿¡Áß¿äÇÑ ¿ªÇÒÀ»ÇÑ´Ù°í¾Ë·ÁÁ®ÀÖ½À´Ï´Ù..
ÀÌÀü±Û
3/28 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ ±è³ª·¡
¾È³çÇϼ¼¿ä À̹øÁÖ ¹ßÇ¥ÀÚ ³ª·¡ÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº ¿ÃÇØ 1¿ù frontiers in microbiology¿¡ °ÔÀçµÈ "CD163ΔSRCR5MARC-145 cells resist PRRSV-2 infection via inhibiting virus uncoating, which require the interaction of CD163 with calpain1"À̶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î, ±âÁ¸¿¡ CD1..